These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16383013)

  • 21. Interplay between different epigenetic modifications and mechanisms.
    Murr R
    Adv Genet; 2010; 70():101-41. PubMed ID: 20920747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutated Chromatin Regulatory Factors as Tumor Drivers in Cancer.
    Koschmann C; Nunez FJ; Mendez F; Brosnan-Cashman JA; Meeker AK; Lowenstein PR; Castro MG
    Cancer Res; 2017 Jan; 77(2):227-233. PubMed ID: 28062403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting DNA methylation in cancer.
    Szyf M
    Bull Cancer; 2006 Sep; 93(9):961-72. PubMed ID: 16980240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic biomarkers.
    Chan TA; Baylin SB
    Curr Top Microbiol Immunol; 2012; 355():189-216. PubMed ID: 21818705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer.
    Baylin SB; Esteller M; Rountree MR; Bachman KE; Schuebel K; Herman JG
    Hum Mol Genet; 2001 Apr; 10(7):687-92. PubMed ID: 11257100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histone acetylation/deacetylation and cancer: an "open" and "shut" case?
    Gray SG; Teh BT
    Curr Mol Med; 2001 Sep; 1(4):401-29. PubMed ID: 11899086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
    Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
    Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of chromatin in human cancer: linking DNA methylation to gene silencing.
    Ballestar E; Esteller M
    Carcinogenesis; 2002 Jul; 23(7):1103-9. PubMed ID: 12117766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic changes in cancer.
    Grønbaek K; Hother C; Jones PA
    APMIS; 2007 Oct; 115(10):1039-59. PubMed ID: 18042143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of histone modifications in epigenetic transitions during normal and perturbed development.
    Kubicek S; Schotta G; Lachner M; Sengupta R; Kohlmaier A; Perez-Burgos L; Linderson Y; Martens JH; O'Sullivan RJ; Fodor BD; Yonezawa M; Peters AH; Jenuwein T
    Ernst Schering Res Found Workshop; 2006; (57):1-27. PubMed ID: 16568946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inactivation of Epigenetic Regulators due to Mutations in Solid Tumors.
    Nemtsova MV; Mikhaylenko DS; Kuznetsova EB; Bykov II; Zamyatnin AA
    Biochemistry (Mosc); 2020 Jul; 85(7):735-748. PubMed ID: 33040718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA methylation: an epigenetic pathway to cancer and a promising target for anticancer therapy.
    Worm J; Guldberg P
    J Oral Pathol Med; 2002 Sep; 31(8):443-9. PubMed ID: 12220350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histone modifications as a pathogenic mechanism of colorectal tumorigenesis.
    Gargalionis AN; Piperi C; Adamopoulos C; Papavassiliou AG
    Int J Biochem Cell Biol; 2012 Aug; 44(8):1276-89. PubMed ID: 22583735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chromatin regulators with tumor suppressor properties and their alterations in human cancers.
    Shu XS; Li L; Tao Q
    Epigenomics; 2012 Oct; 4(5):537-49. PubMed ID: 23130835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.
    Nguyen CT; Gonzales FA; Jones PA
    Nucleic Acids Res; 2001 Nov; 29(22):4598-606. PubMed ID: 11713309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disruption of CTCF/cohesin-mediated high-order chromatin structures by DNA methylation downregulates PTGS2 expression.
    Kang JY; Song SH; Yun J; Jeon MS; Kim HP; Han SW; Kim TY
    Oncogene; 2015 Nov; 34(45):5677-84. PubMed ID: 25703332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromatin (dis)organization and cancer: BUR-binding proteins as biomarkers for cancer.
    Galande S
    Curr Cancer Drug Targets; 2002 Jun; 2(2):157-90. PubMed ID: 12188916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic and epigenetic alterations in carcinogenesis.
    Sugimura T; Ushijima T
    Mutat Res; 2000 Apr; 462(2-3):235-46. PubMed ID: 10767635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA methylation and cancer.
    Kulis M; Esteller M
    Adv Genet; 2010; 70():27-56. PubMed ID: 20920744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.